Abstract
Topical drugs containing corticosteroids are the most frequently used treatments for mild‐to‐moderate psoriasis, but adherence rates to topical drugs are low and up to 80% of psoriasis patients are classified as non‐adherent, which present a barrier to treatment success.3 Barriers to treatment adherence can be divided into socio‐demographic, healthcare, disease, treatment, and patient‐related factors. In a prospective study by Zaghloul et al., adherence to unspecified topical and systemic antipsoriatic drugs was investigated by counting pills or weighing medication bottles; lower adherence was associated with being single, male, or unemployed.
This article is protected by copyright. All rights reserved.
http://bit.ly/2sX8ehr
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου